Results 141 to 150 of about 6,042 (221)

Real-World Benefit of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Findings from a Systematic Literature Review and Meta-Analysis. [PDF]

open access: yesDermatol Ther (Heidelb)
Gottlieb S   +8 more
europepmc   +1 more source

Comparative risk of psoriatic arthritis in psoriasis patients on immunomodulators. [PDF]

open access: yesProc (Bayl Univ Med Cent)
Schmidt M   +3 more
europepmc   +1 more source

Extrapolating Guselkumab Efficacy to Juvenile Psoriatic Arthritis from Adult Psoriatic Arthritis and Adult and Pediatric Psoriasis Data. [PDF]

open access: yesPaediatr Drugs
Crauwels H   +9 more
europepmc   +1 more source

Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis. [PDF]

open access: yesJ Clin Med
Mortato E   +8 more
europepmc   +1 more source

Cutaneous and Genitalia Inflammation Treated With Guselkumab and Antimicrobial Therapy in a Patient with a History of Crohn's Disease. [PDF]

open access: yesACG Case Rep J
Nikzad N   +6 more
europepmc   +1 more source

Severe Delayed Hypersensitivity Reaction at Guselkumab Injection Site. [PDF]

open access: yesContact Dermatitis
Allichon S   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy